DK467385A - Dna-fragmenter - Google Patents

Dna-fragmenter Download PDF

Info

Publication number
DK467385A
DK467385A DK467385A DK467385A DK467385A DK 467385 A DK467385 A DK 467385A DK 467385 A DK467385 A DK 467385A DK 467385 A DK467385 A DK 467385A DK 467385 A DK467385 A DK 467385A
Authority
DK
Denmark
Prior art keywords
dna fragments
fragments
dna
Prior art date
Application number
DK467385A
Other languages
English (en)
Other versions
DK467385D0 (da
Inventor
Y Teranishi
Y Matsui
M Kimura
Y Ikeda
Y Morimoto
Original Assignee
Mitsubishi Chem Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP59216987A external-priority patent/JP2546820B2/ja
Priority claimed from JP60126989A external-priority patent/JPH0653071B2/ja
Application filed by Mitsubishi Chem Ind filed Critical Mitsubishi Chem Ind
Publication of DK467385D0 publication Critical patent/DK467385D0/da
Publication of DK467385A publication Critical patent/DK467385A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK467385A 1984-10-16 1985-10-11 Dna-fragmenter DK467385A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59216987A JP2546820B2 (ja) 1984-10-16 1984-10-16 ヒトアポリポプロテインｅ様蛋白の産生方法
JP60126989A JPH0653071B2 (ja) 1985-06-11 1985-06-11 発現ベクター及び形質転換細胞

Publications (2)

Publication Number Publication Date
DK467385D0 DK467385D0 (da) 1985-10-11
DK467385A true DK467385A (da) 1986-04-17

Family

ID=26463047

Family Applications (1)

Application Number Title Priority Date Filing Date
DK467385A DK467385A (da) 1984-10-16 1985-10-11 Dna-fragmenter

Country Status (6)

Country Link
US (1) US5116739A (da)
EP (1) EP0205715B1 (da)
AU (1) AU587989B2 (da)
CA (1) CA1284774C (da)
DE (1) DE3585953D1 (da)
DK (1) DK467385A (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8712540D0 (en) * 1987-05-28 1987-07-01 Ucb Sa Expression of human proapolipoprotein a-i
EP0345155B1 (en) * 1988-05-31 1994-08-10 Mitsubishi Kasei Corporation Process for producing natural human apolipoprotein e-like proteins
AU658578B2 (en) * 1991-06-26 1995-04-27 Bio-Technology General Corporation Purification of recombinant apolipoprotein E from bacteria
WO1993000443A1 (en) * 1991-06-26 1993-01-07 Bio-Technology General Corp. Purification of recombinant apolipoprotein e from bacteria
EP0710288B1 (en) * 1993-06-10 2006-04-05 Genetic Therapy, Inc. Adenoviral vectors for treatment of hemophilia
SE9500778D0 (sv) * 1995-03-03 1995-03-03 Pharmacia Ab Process for producing a protein
AU720446B2 (en) * 1995-11-01 2000-06-01 Kos Pharmaceuticals, Incorporated Apolipoprotein E2 and treatment of Alzheimer's disease
US20020037867A1 (en) * 1999-02-26 2002-03-28 James M. Wilson Method for recombinant adeno-associated virus-directed gene therapy
ATE338118T1 (de) 1997-12-12 2006-09-15 Univ Western Ontario Neues peptid, apoep1.b, zusammensetzungen und verwendungen davon
WO2005077974A1 (en) * 2004-02-17 2005-08-25 National Public Health Institute IDENTIFICATION OF SNPs ASSOCIATED WITH HYPERLIPIDEMIA, DYSLIPIDEMIA AND DEFECTIVE CARBOHYDRATE METABOLISM
EP1844033B1 (de) * 2005-01-28 2011-07-27 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur herstellung von isochroman und derivaten davon
CN111808084A (zh) 2008-11-10 2020-10-23 阿布特斯生物制药公司 用于递送治疗剂的新型脂质和组合物
EP3243504A1 (en) 2009-01-29 2017-11-15 Arbutus Biopharma Corporation Improved lipid formulation
AU2010223967B2 (en) 2009-03-12 2015-07-30 Alnylam Pharmaceuticals, Inc. Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes
SG10201911942UA (en) 2009-05-05 2020-02-27 Muthiah Manoharan Lipid compositions
KR101766408B1 (ko) 2009-06-10 2017-08-10 알닐람 파마슈티칼스 인코포레이티드 향상된 지질 조성물
AP2015008874A0 (en) 2009-08-14 2015-11-30 Alnylam Pharmaceuticals Inc Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
EP3296398A1 (en) 2009-12-07 2018-03-21 Arbutus Biopharma Corporation Compositions for nucleic acid delivery
EP3494963A1 (en) 2009-12-18 2019-06-12 The University of British Columbia Methods and compositions for delivery of nucleic acids
US20130156845A1 (en) 2010-04-29 2013-06-20 Alnylam Pharmaceuticals, Inc. Lipid formulated single stranded rna
US20130123338A1 (en) 2010-05-12 2013-05-16 Protiva Biotherapeutics, Inc. Novel cationic lipids and methods of use thereof
WO2011141704A1 (en) 2010-05-12 2011-11-17 Protiva Biotherapeutics, Inc Novel cyclic cationic lipids and methods of use
KR20190039347A (ko) 2010-06-03 2019-04-10 알닐람 파마슈티칼스 인코포레이티드 활성제의 전달을 위한 생분해성 지질
WO2012016188A2 (en) 2010-07-30 2012-02-02 Alnylam Pharmaceuticals, Inc. Methods and compositions for delivery of active agents
WO2012016184A2 (en) 2010-07-30 2012-02-02 Alnylam Pharmaceuticals, Inc. Methods and compositions for delivery of active agents
WO2012064824A1 (en) 2010-11-09 2012-05-18 Alnylam Pharmaceuticals, Inc. Lipid formulated compositions and methods for inhibiting expression of eg5 and vegf genes
CA2824526C (en) 2011-01-11 2020-07-07 Alnylam Pharmaceuticals, Inc. Pegylated lipids and their use for drug delivery
HUE042314T2 (hu) 2011-02-07 2019-06-28 Cerenis Therapeutics Holding Sa Lipoprotein komplexek és azok gyártása és alkalmazásai
EP3456317B1 (en) 2011-09-27 2025-09-24 Alnylam Pharmaceuticals, Inc. Di-aliphatic substituted pegylated lipids
WO2014011908A1 (en) 2012-07-11 2014-01-16 Esperion Therapeutics, Inc. Apolipoprotein mixtures
EP3191578B1 (en) * 2014-09-12 2020-11-04 Whitehead Institute for Biomedical Research Cells expressing apolipoprotein e and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4332892A (en) * 1979-01-15 1982-06-01 President And Fellows Of Harvard College Protein synthesis
US4446235A (en) * 1982-03-22 1984-05-01 Genentech, Inc. Method for cloning human growth hormone varient genes
US4578355A (en) * 1983-01-12 1986-03-25 The United States Of America As Represented By The Department Of Health And Human Services Plasmid cloning vector pAS1
US4613572A (en) * 1983-08-15 1986-09-23 Kansas State University Research Foundation Yeast BAR1 gene plasmid
EP0239631A4 (en) * 1985-10-04 1989-01-12 Biotech Res Partners Ltd RECOMBINANT APOLIPOPROTEINS AND METHODS.
GB8712540D0 (en) * 1987-05-28 1987-07-01 Ucb Sa Expression of human proapolipoprotein a-i

Also Published As

Publication number Publication date
EP0205715A1 (en) 1986-12-30
AU4751385A (en) 1986-04-24
CA1284774C (en) 1991-06-11
DE3585953D1 (de) 1992-06-04
EP0205715B1 (en) 1992-04-29
DK467385D0 (da) 1985-10-11
AU587989B2 (en) 1989-09-07
US5116739A (en) 1992-05-26

Similar Documents

Publication Publication Date Title
DK467385A (da) Dna-fragmenter
DK538485D0 (da) Rekombinante dna-molekyler
DK552285A (da) Proteinkonjugat
CY2004007I1 (el) (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamides
AT380762B (de) Hoergeraet
AT379929B (de) Hoergeraet
FR2567014B1 (fr) Lithotripteur
ATA98284A (de) Schalplatte
ATA135485A (de) Maishaecksler
AT386724B (de) Haecksler
FR2563962B3 (fr) Interceps perfectionne
DK395385D0 (da) Varmeapparat
DK319888A (da) Dna-fragmenter
ATA237384A (de) Maehwerk
DK327486D0 (da) Loddekop-forbindelsesorgan
AT389296B (de) Elektrokoagulator
DK51585A (da) Proteinkoncentrater
ES288400Y (es) Clavo
ES278395Y (es) Pipeta mejorada
RO88255A2 (ro) Racord rapid
RO90516A2 (ro) Racord rapid
ES278178Y (es) Cuelga-escobas mejorado
DK161609C (da) Elektroforeseanordning
KR860001448U (ko) 식 칼
FI840484A0 (fi) Baerande akter till motorbaot

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment